LeMaitre Vascular, Inc. (LMAT) vs Anbio Biotechnology (NNNN)

LeMaitre Vascular, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. LeMaitre Vascular, Inc. is the larger, with a market value of $1.9B against $884.9M — 2.1× the size. Across the 9 metrics below, LeMaitre Vascular, Inc. leads on 6 and Anbio Biotechnology on 3.

Valuation

Metric LMAT NNNN Medical Instruments & Supplies median
P/E 28.11 — 34.17
P/S 7.10 — 2.83
P/B 4.43 n/m 2.82
Price to free cash flow 25.25 n/m 25.69
EV/EBITDA 18.70 n/m 16.08
EV/Sales 6.32 n/m 3.06
Earnings yield 3.56% — (1.84%)
Free cash flow yield 3.96% 0.00% 0.17%

Profitability

Metric LMAT NNNN Medical Instruments & Supplies median
Gross margin 72.90% — 54.62%
Operating margin 29.46% — 1.64%
Net margin 25.02% — 0.00%
Free cash flow margin 28.13% 0.00% 1.61%
Return on equity 16.77% 0.00% 0.00%
Return on assets 10.78% 0.00% 0.00%
Return on invested capital 22.67% 0.00% 0.00%

Growth

Metric LMAT NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 11.85% — 9.20%
EPS growth (last fiscal year) 30.57% 150.00% —
Revenue growth, 5-year CAGR 14.05% — 9.48%
Net income growth, 5-year CAGR 22.16% — 0.00%

Health

Metric LMAT NNNN Medical Instruments & Supplies median
Debt to equity 0.40 0.00 0.08
Current ratio 16.31 344.45 2.49
Net debt to EBITDA (2.40) (2.06) 0.83

Dividend

Metric LMAT NNNN Medical Instruments & Supplies median
Dividend yield 0.92% — 0.99%
Payout ratio 0.47 — 0.00

Size

Metric LMAT NNNN Medical Instruments & Supplies median
Market cap 1.85b 884.93m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack